• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cox-2和PPARγ信号通路在抗癌治疗中的应用。

The use of Cox-2 and PPARγ signaling in anti-cancer therapies.

作者信息

Knopfová Lucia, Smarda Jan

机构信息

Department of Experimental Biology, Faculty of Science, Masaryk University, 611 37 Brno, Czech Republic.

出版信息

Exp Ther Med. 2010 Mar;1(2):257-264. doi: 10.3892/etm_00000040. Epub 2010 Mar 1.

DOI:10.3892/etm_00000040
PMID:22993537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3445927/
Abstract

Increased production of the pro-inflammatory enzyme cyclooxygenase-2 (Cox-2) and altered expression and activity of peroxisome proliferator-activated receptor γ (PPARγ) have been observed in many malignancies. Both the PPARγ ligands and the Cox-2 inhibitors possess anti-inflammatory and anti-neoplastic effects in vitro and have been assessed for their therapeutic potential in several pre-clinical and clinical studies. Recently, multiple interactions between PPARγ and Cox-2 signaling pathways have been revealed. Understanding of the cross-talk between PPARγ and Cox-2 might provide important novel strategies for the effective treatment and/or prevention of cancer. This article summarizes recent achievements involving the functional interactions between the PPARγ and Cox-2 signaling pathways and discusses the implications of such interplay for clinical use.

摘要

在许多恶性肿瘤中都观察到促炎酶环氧化酶-2（Cox-2）的产量增加以及过氧化物酶体增殖物激活受体γ（PPARγ）的表达和活性改变。PPARγ配体和Cox-2抑制剂在体外均具有抗炎和抗肿瘤作用，并且已在多项临床前和临床研究中评估了它们的治疗潜力。最近，PPARγ和Cox-2信号通路之间的多种相互作用已被揭示。了解PPARγ和Cox-2之间的相互作用可能为有效治疗和/或预防癌症提供重要的新策略。本文总结了PPARγ和Cox-2信号通路之间功能相互作用的最新成果，并讨论了这种相互作用在临床应用中的意义。

相似文献

1
The use of Cox-2 and PPARγ signaling in anti-cancer therapies.Cox-2和PPARγ信号通路在抗癌治疗中的应用。
Exp Ther Med. 2010 Mar;1(2):257-264. doi: 10.3892/etm_00000040. Epub 2010 Mar 1.
2
The Role of PPARgamma in the Cyclooxygenase Pathway in Lung Cancer.PPARγ 在肺癌中环氧化酶通路中的作用。
PPAR Res. 2008;2008:790568. doi: 10.1155/2008/790568.
3
Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.过氧化物酶体增殖物激活受体γ配体抑制环氧合酶-2的转录激活。激活蛋白-1及CREB结合蛋白/p300参与其中的证据。
J Biol Chem. 2001 Apr 13;276(15):12440-8. doi: 10.1074/jbc.M007237200. Epub 2001 Jan 23.
4
Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.通过过氧化物酶体增殖物激活受体γ调控人宫颈癌细胞中COX-2基因的表达
Clin Cancer Res. 2003 Oct 1;9(12):4627-35.
5
Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells.过氧化物酶体增殖物激活受体γ配体对胃癌细胞生长及基因表达谱的影响
Gut. 2004 Mar;53(3):331-8. doi: 10.1136/gut.2003.021105.
6
Coordinate regulation between the nuclear receptor peroxisome proliferator-activated receptor-γ and cyclooxygenase-2 in renal epithelial cells.核受体过氧化物酶体增殖物激活受体-γ与环氧合酶-2在肾上皮细胞中的协同调节。
Biochem Pharmacol. 2014 Aug 15;90(4):432-9. doi: 10.1016/j.bcp.2014.06.002. Epub 2014 Jun 7.
7
Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.尼美舒利，一种选择性环氧化酶2抑制剂，可抑制人滑膜成纤维细胞中环氧化酶2基因表达的过氧化物酶体增殖物激活受体诱导：受体拮抗的证据。
Arthritis Rheum. 2002 Feb;46(2):494-506. doi: 10.1002/art.10055.
8
Evidence that peroxisome proliferator-activated receptor γ suppresses squamous carcinogenesis through anti-inflammatory signaling and regulation of the immune response.证据表明，过氧化物酶体增殖物激活受体 γ 通过抗炎信号转导和免疫反应的调节抑制鳞状细胞癌变。
Mol Carcinog. 2019 Sep;58(9):1589-1601. doi: 10.1002/mc.23041. Epub 2019 May 20.
9
Interaction of epidermal growth factor with COX-2 products and peroxisome proliferator-activated receptor-γ system in experimental rat Barrett's esophagus.表皮生长因子与 COX-2 产物和过氧化物酶体增殖物激活受体-γ 系统在实验性大鼠 Barrett 食管中的相互作用。
Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G375-G389. doi: 10.1152/ajpgi.00410.2018. Epub 2020 Jan 13.
10
Dexmedetomidine inhibits LPS-induced inflammatory responses through peroxisome proliferator-activated receptor gamma (PPARγ) activation following binding to α adrenoceptors.右美托咪定通过与α肾上腺素受体结合，激活过氧化物酶体增殖物激活受体γ（PPARγ），抑制脂多糖诱导的炎症反应。
Eur J Pharmacol. 2021 Feb 5;892:173733. doi: 10.1016/j.ejphar.2020.173733. Epub 2020 Nov 18.

引用本文的文献

1
Multi-Target Glitazones for Modulating Peroxisome Proliferator-Activated Receptor-γ, Cyclooxygenase-2, and Carbonic Anhydrases for the Management of Metabolic Dysfunction.用于调节过氧化物酶体增殖物激活受体γ、环氧合酶-2和碳酸酐酶以治疗代谢功能障碍的多靶点格列酮类药物
ACS Pharmacol Transl Sci. 2025 May 23;8(6):1627-1658. doi: 10.1021/acsptsci.5c00011. eCollection 2025 Jun 13.
2
Diverse Lenabasum pathway activation in dermatomyositis patients' blood.皮肌炎患者血液中Lenabasum通路的多样化激活
Sci Rep. 2025 May 18;15(1):17232. doi: 10.1038/s41598-025-92001-z.
3
Elucidating the Synergistic Effect of the PrimeC Combination for Amyotrophic Lateral Sclerosis in Human Induced Pluripotent Stem Cell-Derived Motor Neurons and Mouse Models.阐明PrimeC组合对人诱导多能干细胞衍生运动神经元和小鼠模型中肌萎缩侧索硬化症的协同作用。
Pharmaceuticals (Basel). 2025 Apr 3;18(4):524. doi: 10.3390/ph18040524.
4
Dietary polyunsaturated fatty acids affect PPARγ promoter methylation status and regulate the PPARγ/COX2 pathway in some colorectal cancer cell lines.膳食多不饱和脂肪酸会影响某些结直肠癌细胞系中PPARγ启动子的甲基化状态，并调节PPARγ/COX2通路。
Genes Nutr. 2025 Mar 4;20(1):2. doi: 10.1186/s12263-025-00764-x.
5
Repurposed Drugs Celecoxib and Fmoc-L-Leucine Alone and in Combination as Temozolomide-Resistant Antiglioma Agents-Comparative Studies on Normal and Immortalized Cell Lines, and on .来曲唑联合顺铂对人卵巢癌 SKOV3 细胞株的体外抑制作用及其机制
Int J Mol Sci. 2024 Mar 12;25(6):3226. doi: 10.3390/ijms25063226.
6
Plasma-Derived Exosomes from NAFLD Patients Modulate the Cannabinoid Receptors' Expression in Cultured HepaRG Cells.非酒精性脂肪性肝病患者来源的血浆外泌体可调节培养的 HepaRG 细胞中大麻素受体的表达。
Int J Mol Sci. 2023 Jan 16;24(2):1739. doi: 10.3390/ijms24021739.
7
Celecoxib induces adipogenic differentiation of hemangioma-derived mesenchymal stem cells through the PPAR-γ pathway and .塞来昔布通过PPAR-γ途径诱导血管瘤来源的间充质干细胞向脂肪细胞分化。
Exp Ther Med. 2022 Jun;23(6):375. doi: 10.3892/etm.2022.11303. Epub 2022 Apr 7.
8
The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation.内源性大麻素系统和过氧化物酶体增殖物激活受体：专注于它们的信号串扰、作用和转录调控。
Cells. 2021 Mar 7;10(3):586. doi: 10.3390/cells10030586.
9
Celecoxib inhibits acute edema and inflammatory biomarkers through peroxisome proliferator-activated receptor-γ in rats.塞来昔布通过过氧化物酶体增殖物激活受体-γ抑制大鼠急性水肿和炎症生物标志物。
Iran J Basic Med Sci. 2020 Dec;23(12):1544-1550. doi: 10.22038/ijbms.2020.43995.10315.
10
The Association between the Usage of Non-Steroidal Anti-Inflammatory Drugs and Cognitive Status: Analysis of Longitudinal and Cross-Sectional Studies from the Global Alzheimer's Association Interactive Network and Transcriptomic Data.非甾体抗炎药的使用与认知状态之间的关联：来自全球阿尔茨海默病协会互动网络的纵向和横断面研究及转录组数据分析
Brain Sci. 2020 Dec 10;10(12):961. doi: 10.3390/brainsci10120961.

本文引用的文献

1
Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor gamma synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells.抑制COX-2和激活过氧化物酶体增殖物激活受体γ协同抑制人胰腺癌细胞的增殖并诱导其凋亡。
Cancer Lett. 2009 Mar 18;275(2):247-55. doi: 10.1016/j.canlet.2008.10.023. Epub 2008 Dec 3.
2
Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.过氧化物酶体增殖物激活受体γ及其配体在前列腺癌中的生长抑制作用
Cancer Detect Prev. 2008;32(3):259-66. doi: 10.1016/j.cdp.2008.05.008. Epub 2008 Sep 11.
3
The Role of PPARgamma in the Cyclooxygenase Pathway in Lung Cancer.PPARγ 在肺癌中环氧化酶通路中的作用。
PPAR Res. 2008;2008:790568. doi: 10.1155/2008/790568.
4
Eicosapentaenoic acid inhibits interleukin-6 production in interleukin-1beta-stimulated C6 glioma cells through peroxisome proliferator-activated receptor-gamma.二十碳五烯酸通过过氧化物酶体增殖物激活受体γ抑制白细胞介素-1β刺激的C6胶质瘤细胞中白细胞介素-6的产生。
Prostaglandins Leukot Essent Fatty Acids. 2008 Jul-Aug;79(1-2):59-65. doi: 10.1016/j.plefa.2008.07.002. Epub 2008 Aug 30.
5
Suppression of tumor formation by a cyclooxygenase-2 inhibitor and a peroxisome proliferator-activated receptor gamma agonist in an in vivo mouse model of spontaneous breast cancer.在自发性乳腺癌的体内小鼠模型中，环氧化酶-2抑制剂和过氧化物酶体增殖物激活受体γ激动剂对肿瘤形成的抑制作用。
Clin Cancer Res. 2008 Aug 1;14(15):4935-42. doi: 10.1158/1078-0432.CCR-08-0958.
6
15-deoxy-delta 12,14-prostaglandin J(2) inhibits the synthesis of the acute phase protein SIP24 in cartilage: Involvement of COX-2 in resolution of inflammation.15-脱氧-Δ12,14-前列腺素J2抑制软骨中急性期蛋白SIP24的合成：环氧合酶-2参与炎症消退过程
J Cell Physiol. 2008 Nov;217(2):433-41. doi: 10.1002/jcp.21516.
7
The Role of PPAR-gamma and Its Interaction with COX-2 in Pancreatic Cancer.过氧化物酶体增殖物激活受体-γ及其与环氧化酶-2在胰腺癌中的作用。
PPAR Res. 2008;2008:326915. doi: 10.1155/2008/326915.
8
Peroxisome proliferator-activated receptor-gamma agonists and diabetes: current evidence and future perspectives.过氧化物酶体增殖物激活受体γ激动剂与糖尿病：当前证据与未来展望。
Vasc Health Risk Manag. 2008;4(2):297-304. doi: 10.2147/vhrm.s993.
9
Combination therapy of S-1 with selective cyclooxygenase-2 inhibitor for liver metastasis of colorectal carcinoma.S-1与选择性环氧化酶-2抑制剂联合治疗结直肠癌肝转移
Anticancer Res. 2008 Mar-Apr;28(2A):629-38.
10
A phase II study of carboplatin and paclitacel with meloxicam.卡铂、紫杉醇与美洛昔康的II期研究。
Lung Cancer. 2009 Jan;63(1):72-6. doi: 10.1016/j.lungcan.2008.04.002. Epub 2008 May 21.